BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma & Biopharma Manufacturing

WuXi XDC and Celltrion Collaborate on Comprehensive Antibody-Drug Conjugate (ADC) Services

Under the collaboration, Celltrion will delegate WuXi XDC as primary service provider on each of the integrated projects, from process development to GMP m...

January 24, 2024 | News

Sagimet Biosciences Reports Positive Results in Phase 2b Trial of Denifanstat for F2/F3 NASH

- Primary efficacy endpoints: NASH resolution without worsening of fibrosis with ≥2-point reduction in NAS (NAFLD Activity Score) in ...

January 24, 2024 | News

Kindeva Drug Delivery Acquires Summit Biosciences, a Nasal Drug Development Specialist

The acquisition of Summit enhances Kindeva’s existing drug-delivery capabilities by adding a new drug-delivery platform, further expanding Kindeva&rs...

January 19, 2024 | News

Thermo Fisher Scientific Introduces First Off-the-Shelf Validated Software for Automated Cell Therapy Manufacturing

To optimize clinical manufacturing processes for innovators developing breakthrough cell therapies, Thermo Fisher Scientific today announced the laun...

January 18, 2024 | News

Charles River Streamlines AAV Vector Manufacturing with Rep/Cap Plasmids Launch

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline...

January 17, 2024 | News

Boehringer Ingelheim Invests EUR 120 Million in Greek Plant Expansion for Enhanced Medication Manufacturing and Job Creation

Main disease areas include cardio-renal-metabolic (CRM) diseases, mental health, pulmonary fibrosis, systemic sclerosis, and chronic liver disease, some of...

January 12, 2024 | News

GBI Strengthens Radiopharmaceutical Manufacturing Leadership with Commercial Manufacturing Contract

"We are thrilled to announce the signing of our second commercial contract, a testament to the exceptional capabilities and unwavering commitment of the en...

January 11, 2024 | News

WuXi AppTec Triples Peptide Capacity, Launches Taixing API Site

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech an...

January 09, 2024 | News

Kexing Biopharm Expands Global Portfolio with Eribulin Mesylate Injection

Eribulin Mesylate Injection is indicated for patients with locally advanced or metastatic breast cancer who have undergone at least two chemotherapy r...

January 08, 2024 | News

AstraZeneca Acquires Gracell, Expanding Cell Therapy Goals in Oncology and Autoimmune Diseases.

AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceuti...

December 28, 2023 | News

PharmaBlock Sciences Unveils State-of-the-Art High Potency API Facility in Zhejiang Site.

The new HPAPI GMP facility enables PharmaBlock to offer process R&D and kilo-scale production of HPAPIs and ADC toxins. It spans an area of 1...

December 28, 2023 | News

GenSci Launches Global Innovation Hub in Shanghai

Changchun GeneScience Pharmaceutical ("GenSci"), a subsidiary of Changchun High-Tech Industries (Group), held a groundbreaking ceremony for its new global ...

December 26, 2023 | News

Dr. Reddy’s First Indian Pharma Firm to Join Dow Jones Sustainability World Index

In a first for Indian pharma, Dr. Reddy’s is featured in the Dow Jones Sustainability World Index for 2023 Company retains its place in the ...

December 15, 2023 | News

Full-Life Technologies Begins Construction on GMP Manufacturing Facility in Belgium for Radiopharmaceuticals

This strategic investment aims to advance Full-Life's end-to-end solution by enhancing its radiopharmaceutical production capabilities at a key logistical ...

December 08, 2023 | News

Stay Connected